Description

BSE notifies trading members that Rights Entitlements (REs) for Healthcare Global Enterprises Limited will be available for renunciation trading from March 11 to March 20, 2026, settled on T+1 rolling basis.

Summary

BSE has notified trading members that Rights Entitlements (REs) for Healthcare Global Enterprises Limited (Scrip Code: 751095, Scrip ID: HCG-RE) will be available for renunciation trading on the Exchange effective Wednesday, March 11, 2026. The REs will trade under T+1 rolling settlement on a trade-for-trade basis in dematerialized form only.

Key Points

  • Rights Entitlements (REs) for renunciation of Healthcare Global Enterprises Limited are permitted on BSE from March 11, 2026
  • Scrip Code: 751095 | Scrip ID: HCG-RE | ISIN: INE075I20017
  • Market Lot: 1 | Group: R
  • REs are tradable in dematerialized form only
  • Settlement is on T+1 Rolling Settlement basis, trade-for-trade
  • Trading members must inform clients about the RE ISIN and clarify it is not the same as ordinary shares
  • Contract notes must include a prominent disclaimer about the nature of REs
  • Unlapsed, unrenounced REs will be extinguished after the Issue Closing Date

Regulatory Changes

No new regulatory changes. This circular implements existing RE trading framework per BSE Notice No. 20200305-21 (March 5, 2020) and Notice No. 20200518-34 (May 18, 2020).

Compliance Requirements

  • Trading members must notify all clients about the commencement of RE trading, specifying the ISIN (INE075I20017)
  • Members must clarify that REs are not ordinary shares of Healthcare Global Enterprises Limited
  • Contract notes and bills for RE purchases must prominently display a disclaimer stating that purchasing REs only grants the right to participate in the rights issue or renounce before closing
  • Members should refer to earlier notices (20200305-21 and 20200518-34) for further procedural details

Important Dates

  • RE Trading Period: March 11, 2026 to March 20, 2026
  • Rights Issue Open Date: March 11, 2026
  • Rights Issue Close Date: March 25, 2026
  • RE Lapse: After March 25, 2026 (Issue Closing Date), unsubscribed and unrenounced REs will be extinguished

Impact Assessment

This circular has a moderate, time-bound impact on trading members and existing shareholders of Healthcare Global Enterprises Limited. Shareholders who received REs can either apply for the rights issue with application money or renounce their entitlements by selling during the March 11–20, 2026 window. The trade-for-trade and T+1 settlement mechanism limits speculative activity. Members face compliance obligations around client disclosure and contract note disclaimers.

Impact Justification

Routine rights entitlement trading notification affecting existing shareholders and trading members dealing in HCG securities; limited to a specific trading window.